HTG Molecular Diagnostics (HTGM) Reports Q1 Loss Per Share of $14.99
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Partners Starts HTG Molecular Diagnostics (HTGM) at Outperform
June 2, 2015 6:57 AM EDTLeerink Partners initiates coverage on HTG Molecular Diagnostics (NASDAQ: HTGM) with a Outperform rating and a price target of $18.00.
Analyst Dan Leonard commented, "We are initiating coverage of Tucson, AZ-based HTG Molecular, Inc. (HTGM) with an Outperform rating and an $18... More
